I thought it might be time to for me to "sign in" to this board to share some perspectives occasionally. First of all, I guess I am considered a "core" investor. Second of all, I am a pharmacist and I also have over 25 years of experience in the pharma industry. I just want to comment at this time on Guts' comments about the potential of a compounding pharmacy (where I also have experience). He is correct that the potential, at this time, is great for revenues in this segment of the market. At some point in time, and no one knows when that might be, the potential for those revenues could decrease due to competition and 3rd party (insurance) payment scenarios. THIS IS NOT MEANT TO BE A NEGATIVE, only an awareness that the approach of building multiple revenue streams, each with it's own strength, is and should be the approach for long term viability of SCRC. I am convinced that leadership of the company is aware of all of this and is doing "the right thing" for all of us.